Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel patent CN114315823B enables safer berberine intermediate production without cyanide. Reduces costs and enhances supply chain reliability for global pharmaceutical manufacturers seeking high purity.
Patent CN1712399B details a novel hybrid synthesis of paclitaxel-MDP conjugates improving solubility and efficacy. Discover cost-effective manufacturing strategies for advanced API intermediates.
Novel Pd-catalyzed carbonylation method for quinazolinones. Enhances purity and reduces toxic gas usage for scalable API manufacturing.
Patent CN112480015A reveals a novel Pd-catalyzed one-pot method for 2-trifluoromethyl quinazolinones, offering significant cost reduction in API manufacturing and improved supply chain reliability.
This patent details a cobalt-catalyzed synthesis method offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing without precious metals.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for scalable pharmaceutical intermediate production.
Patent CN115286553B reveals a novel nickel-catalyzed carbonylation method for indole synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN106279014A details a Pd-catalyzed method for phenylglycine derivatives, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Novel palladium-catalyzed carbonylation method for quinoline-4(1H)-one. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN113582929B details a novel Pd-catalyzed decarboxylative cyclization for 2,5-disubstituted imidazoles. This method offers superior atom economy and cost reduction in API manufacturing.
Novel Ni-catalyzed asymmetric method for chiral quaternary carbon alpha-amino acid esters. High yield, excellent ee, scalable process for API intermediates.
Patent CN112480015B reveals a novel one-pot synthesis for 2-trifluoromethyl quinazolinones using nitro compounds, offering cost reduction in API manufacturing and scalable production.
Novel one-pot method for 2-trifluoromethyl quinazolinones using nitro compounds. High yield, scalable process for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method for indole and benzoxazine compounds. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Novel one-step synthesis method for heterocyclic intermediates. Reduces complexity and enhances supply chain reliability for pharmaceutical manufacturing.
Novel Pd-catalyzed synthesis patent CN116640146A offers high efficiency. Reliable supply chain and cost reduction in pharmaceutical intermediates manufacturing for global partners.
Patent CN118619879A details a novel Rhodium-catalyzed route for trifluoromethyl enaminones, offering significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Patent CN107021866A details a Lewis acid catalyzed route for chain enyne compounds. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN113683595B reveals sulfur-promoted triazole synthesis offering safety and cost advantages for pharmaceutical intermediate manufacturing supply chains.
Patent CN104098518B offers azide-free triazole synthesis. Enhances supply chain safety and reduces manufacturing costs for pharmaceutical intermediates globally.